Portfolio

VisageX Medical

Facial implants for the aesthetics and reconstructive surgery market

Now Funding

Technology Development

Business Development

Revenue

Exited

Visit Website
Founded

2022

CEO
Gideon Meyer Brodnitz
UN SDGs
3
Contact Us
email
Follow Us
linkedin
Investors
The Trendlines Group ; the Israel Innovation Authority

About

VisageX Medical specializes in developing adjustable facial implants tailored for the aesthetics and reconstructive surgery market.

What sets us apart is our unique technology, allowing for the modification of implant shape and size long after the surgery is complete.

Our first-in-human study is scheduled for 2024.

Market Need

The global market for facial plastic and reconstructive implants is projected to reach $1.6 billion by 2033, with a compound annual growth rate (CAGR) of 7.8%. VisageX holds a substantial competitive advantage, as there are currently no direct competitors offering a comparable product solution. We anticipate that our technology will significantly alter patient treatment paradigms, attracting increased adoption

Skip to content